In order to further strengthen the scientific and technological support for the development of new coronavirus testing products for epidemic prevention and control, the Ministry of Science and Technology, together with the Food and Drug Administration, released the "Novel Coronavirus (2019-nCoV) Rapid Testing Product Development" project application guide on February 8. Guangdong Hecin Scientific, Inc. responded positively and quickly handed over the new coronavirus on-site rapid diagnostic reagent solution. On February 19, the project was recommended by the Office of the Joint Prevention and Control Mechanism (Scientific Research Group) of the State Council to respond to the new coronavirus epidemic and was included in the emergency approval channel.

The recommended kit uses colloidal gold immunochromatography technology to detect human novel coronavirus (2019-nCoV) IgM antibodies. The test results can be obtained by naked eye observation within 15 minutes by taking only one drop of blood, which can effectively break through the existing detection technology for personnel. , limiting the location, shortening the testing time, achieving rapid diagnosis of suspected patients and on-site screening of people in close contact.

As a member of the industry-university-research team of Guangdong Hecin Scientific, Inc. relies on the platform of the National Key Laboratory of Respiratory Diseases to focus on the detection of respiratory pathogens and actively develop various testing projects for respiratory pathogens to ensure that the detection scope covers most respiratory pathogens; develop different Methodological testing platform to ensure that it meets the needs of various types of hospitals. In the field of respiratory pathogen detection, Guangdong Hecin Scientific, Inc. will continue to delve into it with a more professional and in-depth attitude. In this battle against the new coronavirus-infected pneumonia, Guangdong Hecin Scientific, Inc. is unshirkable in its responsibility to give full play to the company's innovative research and development capabilities to help curb the spread of the epidemic!